Roidipedia.Compound reference & reporting
05 AUG 2026
CompoundsAnabolic steroid 11-Keto-DHEA (11-Oxo-DHEA)
Anabolic steroidProhormoneOralAndrogen precursor11-oxyandrogen

11-Keto-DHEA (11-Oxo-DHEA)

Also known as 11-oxo-DHEA · 11-ketodehydroepiandrosterone

An 11-oxygenated DHEA analog positioned as a precursor to 11-keto androgens (the 11-oxyandrogen pathway now recognised as clinically relevant). Marketed as a mild recomposition prohormone with limited human data and an uncertain regulatory footing.

01 Overview

11-Keto-DHEA (11-oxo-dehydroepiandrosterone) is an 11-oxygenated steroid tied to the 11-oxyandrogen pathway, a class of adrenal-derived androgens (such as 11-ketotestosterone) that has drawn recent clinical attention for its contribution to total androgen activity, particularly in conditions like PCOS and congenital adrenal hyperplasia.

As a supplement it is promoted as a precursor to 11-keto androgens for lean recomposition with supposedly low aromatisation. Direct human data on supplementation are minimal, and its status as a lawful ingredient is unsettled; structurally related 11-oxo compounds have been treated as controlled anabolic agents.

02 Mechanism

Positioned as a precursor within the 11-oxyandrogen pathway, potentially yielding 11-keto androgens such as 11-ketotestosterone via 17-beta-HSD/11-HSD steps; low aromatisation expected.

03 Dosing

TierDoseRouteNotes
Label-typical50–150 mg/dayOralReported supplement dosing; efficacy unproven.

Ester comparison

EsterHalf-lifeInjection freq.Testosterone by mass

04 Effects

EffectMagnitudeEvidence
11-keto androgen support (claimed)Proposed to raise 11-oxyandrogen activity; 11-ketotestosterone is a bona fide active androgen, but supplement conversion in humans is unstudied.Unquantified in humansPreclinical
Low aromatisation11-oxygenated androgens aromatise poorly, limiting estrogenic effects.Minimal estrogen conversionPreclinical

05 Side effects

EffectSeverityFrequencyEvidenceCountermeasures
Androgenic effectsAcne or oily skin if meaningful androgen conversion occurs.MildUncommonAnecdotal
Possible HPTA suppressionSuppression plausible if androgen conversion is significant, but unquantified.MildUnknownUnconfirmed

07 References

The 11-oxyandrogen pathway and 11-ketotestosteroneJ Clin Endocrinol Metab, 2017
11-Oxygenated androgens in human physiologyEndocrine Reviews, 2021

08 Discussion0 comments

?
Sign in to add a comment…
Create account
Discussion is moderated. No sourcing, vendor names or price talk — those comments are removed, and repeat posts are banned.
This page is reference information, not medical advice. Doses and protocols are documented as they appear in the clinical literature and in practice — describing them is not a recommendation to use them. Countermeasures listed here are not a substitute for a physician. Legal status varies by jurisdiction and changes.